Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $374.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Emergent BioSolutions Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $25.2K in total
- Insiders trading
- 1
- Net value
- −$25.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Emergent BioSolutions Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Williams Paul Anthony | SVP, Products Business | 159,098 | Jul 2, 2026 | 7 |
| Lindahl Richard S | EVP, Chief Financial Officer | 374,083 | Jun 10, 2026 | 7 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | 202,201 | Jun 10, 2026 | 6 |
| Hartzel William | SVP, Bioservices | 185,558 | Jun 10, 2026 | 5 |
| Fowler John D Jr | Director | 30,350 | May 4, 2026 | 2 |
| Katkin Keith | Director | 96,294 | May 4, 2026 | 1 |
| Richard Ronald | Director | 123,761 | May 4, 2026 | 2 |
| Harsanyi Zsolt | Chairman | 149,076 | May 4, 2026 | 1 |
| White Marvin L | Director | 113,839 | May 4, 2026 | 1 |
| Fowler Neal Franklin | Director | 160,847 | May 4, 2026 | 1 |
| Dayal Sujata Tyagi | Director | 100,563 | May 4, 2026 | 2 |
| DeGolyer Donald W | Director | 129,721 | May 4, 2026 | 2 |
| Zoon Kathryn C | Director | 79,941 | May 4, 2026 | 1 |
| Papa Joseph C | President and CEO | 493,153 | May 1, 2026 | 2 |
| Perl Jessica | SVP, General Counsel, Corp Sec | 165,286 | May 1, 2026 | 3 |
| Lowry Simon C | SVP, R&D, CMO | 177,914 | May 1, 2026 | 3 |
| Sullivan Louis W | Director | 139,098 | May 2, 2025 | 0 |
| Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | 186,382 | Jul 12, 2024 | 0 |
| Kramer Robert | President and CEO | 506,059 | Jun 13, 2023 | 0 |
| Havey Adam | EVP, Business Operations | 174,398 | Jun 13, 2023 | 0 |
| Hauer Jerome M | Director | 57,508 | May 30, 2023 | 0 |
| Saran Atul | EVP, Chief Strat & Dev Officer | 86,645 | Mar 2, 2023 | 0 |
| Strei Katherine | EVP, Chief HR Officer | 62,824 | Mar 2, 2023 | 0 |
| Joulwan George A | Director | 40,244 | May 31, 2022 | 0 |
| El-Hibri Fuad | Director | 206,434Indirect | Dec 7, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)12:57 PM ET | Jul 1 | 1 day | Williams Paul AnthonySVP, Products Business | SSale | −3.00K | $8.40 | −$25.2K | −1.9%159.1K after | 10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Zoon Kathryn CDirector | SSale | −17.2K | $8.40 | −$144.5K | −17.7%79.9K after | 2 lots10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | DeGolyer Donald WDirector | SSale | −15.5K | $8.40 | −$130.0K | −10.7%129.7K after | 2 lots10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Dayal Sujata TyagiDirector | SSale | −13.8K | $8.40 | −$115.6K | −12.0%100.6K after | 2 lots10b5-1 |
| May 4, 2026 (view filing) | Apr 30 | 4 days | Katkin KeithDirector | SSale | −15.5K | $8.28 | −$128.2K | −13.9%96.3K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Williams Paul AnthonySVP, Products Business | SSale | −4.00K | $8.44 | −$33.8K | −6.0%62.7K after | 10b5-1 |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Richard RonaldDirector | SSale | −22.0K | $11.97 | −$263.1K | −18.3%98.4K after | 2 lots |
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | DeGolyer Donald WDirector | SSale | −17.8K | $10.54 | −$187.6K | −12.9%119.9K after | |
| Nov 10, 2025 (view filing) | Nov 7 | 3 days | Dayal Sujata TyagiDirector | SSale | −8.55K | $10.00 | −$85.5K | −8.8%89.0K after | |
| Oct 16, 2025 (view filing) | Oct 7 | 9 daysLate | Glessner ColeenEVP, Quality & Ethics, and CPL | SSale | −30.6K | $10.00 | −$306.1K | −17.5%144.3K after | |
| Aug 18, 2025 (view filing) | Aug 15 | 3 days | Zoon Kathryn CDirector | SSale | −7.09K | $8.87 | −$62.9K | −9.0%71.8K after | 10b5-1 |
| Aug 13, 2025 (view filing) | Aug 12 | 1 day | DeGolyer Donald WDirector | SSale | −7.84K | $8.65 | −$67.9K | −5.4%137.7K after | |
| May 28, 2025 (view filing) | May 23 | 5 days | Katkin KeithDirector | SSale | −7.84K | $6.30 | −$49.4K | −8.3%86.4K after | 10b5-1 |
| May 15, 2025 (view filing) | May 13 | 2 days | Papa Joseph CPresident and CEO | PPurchase | +60.0K | $5.83 | +$349.8K | +21.2%342.5K after | |
| Mar 12, 2025 (view filing) | Mar 12 | Same day | Fowler Neal FranklinDirector | SSale | −35.0K | $5.83 | −$204.1K | −25.7%101.1K after | |
| Mar 12, 2025 (view filing) | Mar 12 | Same day | Zoon Kathryn CDirector | SSale | −10.0K | $5.73 | −$57.3K | −18.4%44.5K after | |
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | DeGolyer Donald WDirector | SSale | −25.0K | $10.91 | −$272.8K | −18.4%111.1K after | |
| Nov 13, 2024 (view filing) | Nov 11 | 2 days | White Marvin LDirector | SSale | −14.3K | $11.97 | −$171.0K | −20.9%54.1K after | |
| Jun 6, 2024 (view filing) | Jun 4 | 2 days | Zoon Kathryn CDirector | SSale | −10.0K | $6.11 | −$61.1K | −15.5%54.5K after | |
| May 31, 2024 (view filing) | May 29 | 2 days | Zoon Kathryn CDirector | SSale | −1.83K | $4.61 | −$8.44K | −2.8%64.5K after | |
| May 23, 2024 (view filing) | May 21 | 2 days | Zoon Kathryn CDirector | SSale | −1.09K | $5.78 | −$6.29K | −2.2%48.9K after | |
| Jul 24, 2023 (view filing) | May 25-Jun 2 | 60 daysLate | Zoon Kathryn CDirector | SSale | −3.53K | $8.36 | −$29.5K | −6.6%50.0K after | 2 lots10b5-1 |
| Nov 29, 2022 (view filing) | Nov 25 | 4 days | Richard RonaldDirector | SSale | −1.91K | $11.94 | −$22.8K | −8.8%19.8K after | |
| Jun 13, 2022 (view filing) | Jun 9 | 4 days | Zoon Kathryn CDirector | SSale | −1.17K | $31.52 | −$37.0K | −5.6%19.7K after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Zoon Kathryn CDirector | SSale | −2.00K | $35.53 | −$70.9K | −13.9%12.4K after | |
| Nov 15, 2021 (view filing) | Nov 15 | Same day | Lindahl Richard SEVP, Chief Financial Officer | PPurchase | +3.00K | $37.46 | +$112.4K | +8.1%39.9K after |